These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36991247)

  • 1. Resveratrol and Dulaglutide ameliorate adiposity and liver dysfunction in rats with diet-induced metabolic syndrome: Role of SIRT-1 / adipokines / PPARγ and IGF-1.
    Shamardl HAMA; Ibrahim NA; Merzeban DH; Elamir AM; Golam RM; Elsayed AM
    Daru; 2023 Jun; 31(1):13-27. PubMed ID: 36991247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Singular effects of PPAR agonists on nonalcoholic fatty liver disease of diet-induced obese mice.
    Barbosa-da-Silva S; Souza-Mello V; Magliano DC; Marinho Tde S; Aguila MB; Mandarim-de-Lacerda CA
    Life Sci; 2015 Apr; 127():73-81. PubMed ID: 25748419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in vitro and in vivo study of a 4-herb formula on the management of diet-induced metabolic syndrome.
    Wat E; Wang Y; Chan K; Law HW; Koon CM; Lau KM; Leung PC; Yan C; Lau CBS
    Phytomedicine; 2018 Mar; 42():112-125. PubMed ID: 29655677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-targeting strategy to ameliorate high-fat-diet- and fructose-induced (western diet-induced) non-alcoholic fatty liver disease (NAFLD) with supplementation of a mixture of legume ethanol extracts.
    Koh YC; Lin YC; Lee PS; Lu TJ; Lin KY; Pan MH
    Food Funct; 2020 Sep; 11(9):7545-7560. PubMed ID: 32815965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD).
    Wang Z; Li S; Wang R; Guo L; Xu D; Zhang T; Xu Y; Wang W; Wang M; Gan Z; Wang X
    Mol Med; 2020 Jun; 26(1):54. PubMed ID: 32503411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis.
    Awad AS; Abd Al Haleem EN; El-Bakly WM; Sherief MA
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):381-91. PubMed ID: 26753695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ugonin J improves metabolic disorder and ameliorates nonalcoholic fatty liver disease by regulating the AMPK/AKT signaling pathway.
    Chang TC; Chiou WC; Lai WH; Huang HC; Huang YL; Liu HK; Liang YC; Huang C
    Pharmacol Res; 2021 Jan; 163():105298. PubMed ID: 33220422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salidroside and Curcumin Formula Prevents Liver Injury in Nonalcoholic Fatty Liver Disease in Rats.
    Li HS
    Ann Hepatol; 2018 Aug; 17(5):769-778. PubMed ID: 30145577
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Huang HC; Chen CJ; Lai YH; Lin YC; Chiou WC; Lu HF; Chen YF; Chen YH; Huang C
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33808007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating hyperuricemia related non-alcoholic fatty liver disease in rats with resveratrol.
    Xu K; Liu S; Zhao X; Zhang X; Fu X; Zhou Y; Xu K; Miao L; Li Z; Li Y; Qiao L; Bao J
    Biomed Pharmacother; 2019 Feb; 110():844-849. PubMed ID: 30557833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gluten-free diet reduces adiposity, inflammation and insulin resistance associated with the induction of PPAR-alpha and PPAR-gamma expression.
    Soares FL; de Oliveira Matoso R; Teixeira LG; Menezes Z; Pereira SS; Alves AC; Batista NV; de Faria AM; Cara DC; Ferreira AV; Alvarez-Leite JI
    J Nutr Biochem; 2013 Jun; 24(6):1105-11. PubMed ID: 23253599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed intervention with a novel SGLT2 inhibitor NGI001 suppresses diet-induced metabolic dysfunction and non-alcoholic fatty liver disease in mice.
    Chiang H; Lee JC; Huang HC; Huang H; Liu HK; Huang C
    Br J Pharmacol; 2020 Jan; 177(2):239-253. PubMed ID: 31497874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect and mechanism of Qiwei Tiexie capsule on 3T3-L1 adipocytes cells and rats with nonalcoholic fatty liver disease by regulating LXRα, PPARγ, and NF-κB-iNOS-NO signaling pathways.
    Suolang PC; Liu BQ; Chen J; De J; Nima ZB; Dunzhu CR
    J Ethnopharmacol; 2019 May; 236():316-325. PubMed ID: 30851372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An unbiased lipidomics approach identifies key lipid molecules as potential therapeutic targets of Dohongsamul-tang against non-alcoholic fatty liver diseases in a mouse model of obesity.
    Park SH; Lee JE; Lee SM; Lee J; Seo CS; Hwang GS; Jung J
    J Ethnopharmacol; 2020 Oct; 260():112999. PubMed ID: 32454173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Sitosterol Circumvents Obesity Induced Inflammation and Insulin Resistance by down-Regulating IKKβ/NF-κB and JNK Signaling Pathway in Adipocytes of Type 2 Diabetic Rats.
    Jayaraman S; Devarajan N; Rajagopal P; Babu S; Ganesan SK; Veeraraghavan VP; Palanisamy CP; Cui B; Periyasamy V; Chandrasekar K
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33917607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of combined PPAR-γ and PPAR-α agonist therapy on fructose induced NASH in rats: Modulation of gene expression.
    Abd El-Haleim EA; Bahgat AK; Saleh S
    Eur J Pharmacol; 2016 Feb; 773():59-70. PubMed ID: 26825546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mulberry Leaf Extracts prevent obesity-induced NAFLD with regulating adipocytokines, inflammation and oxidative stress.
    Peng CH; Lin HT; Chung DJ; Huang CN; Wang CJ
    J Food Drug Anal; 2018 Apr; 26(2):778-787. PubMed ID: 29567249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postnatal programming of glucocorticoid metabolism in rats modulates high-fat diet-induced regulation of visceral adipose tissue glucocorticoid exposure and sensitivity and adiponectin and proinflammatory adipokines gene expression in adulthood.
    Boullu-Ciocca S; Achard V; Tassistro V; Dutour A; Grino M
    Diabetes; 2008 Mar; 57(3):669-77. PubMed ID: 18057089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antrodan Alleviates High-Fat and High-Fructose Diet-Induced Fatty Liver Disease in C57BL/6 Mice Model via AMPK/Sirt1/SREBP-1c/PPARγ Pathway.
    Chyau CC; Wang HF; Zhang WJ; Chen CC; Huang SH; Chang CC; Peng RY
    Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31935815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of endoplasmic reticulum stress via sulforaphane-mediated AMPK upregulation against nonalcoholic fatty liver disease in rats.
    Mansour SZ; Moustafa EM; Moawed FSM
    Cell Stress Chaperones; 2022 Sep; 27(5):499-511. PubMed ID: 35779187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.